Honeychurch J - Search Results

1

Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.

Du Y, Honeychurch J, Glennie M, Johnson P, Illidge T. Du Y, et al. Among authors: honeychurch j. Cancer Res. 2007 Feb 1;67(3):1335-43. doi: 10.1158/0008-5472.CAN-06-2495. Cancer Res. 2007. PMID: 17283171

2

Bispecific Ab therapy of B-cell lymphoma: target cell specificity of antibody derivatives appears critical in determining therapeutic outcome.

Honeychurch J, Cruise A, Tutt AL, Glennie MJ. Honeychurch J, et al. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):171-3. doi: 10.1007/s002620050425. Cancer Immunol Immunother. 1997. PMID: 9435866 Free PMC article.

3

Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors.

Tutt AL, French RR, Illidge TM, Honeychurch J, McBride HM, Penfold CA, Fearon DT, Parkhouse RM, Klaus GG, Glennie MJ. Tutt AL, et al. Among authors: honeychurch j. J Immunol. 1998 Sep 15;161(6):3176-85. J Immunol. 1998. PMID: 9743386

4

Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma.

Honeychurch J, Tutt AL, Valerius T, Heijnen IA, Van De Winkel JG, Glennie MJ. Honeychurch J, et al. Blood. 2000 Nov 15;96(10):3544-52. Blood. 2000. PMID: 11071653 Free article.

5

A new in vivo and in vitro B cell lymphoma model, pi-BCL1.

Illidge T, Honeychurch J, Howatt W, Ross F, Wilkins B, Cragg M. Illidge T, et al. Among authors: honeychurch j. Cancer Biother Radiopharm. 2000 Dec;15(6):571-80. doi: 10.1089/cbr.2000.15.571. Cancer Biother Radiopharm. 2000. PMID: 11190489

6

Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: efficacy depends on more than targeted irradiation alone.

Illidge T, Honeychurch J, Vandersteen A, Cragg M. Illidge T, et al. Among authors: honeychurch j. Cancer Biother Radiopharm. 2000 Dec;15(6):581-91. doi: 10.1089/cbr.2000.15.581. Cancer Biother Radiopharm. 2000. PMID: 11190490

7

Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide.

Lee-MacAry AE, Ross EL, Davies D, Laylor R, Honeychurch J, Glennie MJ, Snary D, Wilkinson RW. Lee-MacAry AE, et al. Among authors: honeychurch j. J Immunol Methods. 2001 Jun 1;252(1-2):83-92. doi: 10.1016/s0022-1759(01)00336-2. J Immunol Methods. 2001. PMID: 11334968

8

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma.

Honeychurch J, Glennie MJ, Johnson PW, Illidge TM. Honeychurch J, et al. Blood. 2003 Aug 15;102(4):1449-57. doi: 10.1182/blood-2002-12-3717. Epub 2003 Apr 24. Blood. 2003. PMID: 12714523 Free article.

9

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy.

Du Y, Honeychurch J, Cragg MS, Bayne M, Glennie MJ, Johnson PW, Illidge TM. Du Y, et al. Among authors: honeychurch j. Blood. 2004 Feb 15;103(4):1485-94. doi: 10.1182/blood-2003-06-2037. Epub 2003 Oct 23. Blood. 2004. PMID: 14576070 Free article.

10

Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.

Honeychurch J, Glennie MJ, Illidge TM. Honeychurch J, et al. Cancer Res. 2005 Aug 15;65(16):7493-501. doi: 10.1158/0008-5472.CAN-04-3808. Cancer Res. 2005. PMID: 16103104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters